Independent guidance
Lumaquay is an independent resource on ibogaine treatment considerations in Los Angeles and beyond. Our mission is to give people plainspoken, evidence-aware information so they can assess legal status, safety concerns, and continuity-of-care questions with clarity.
Mission
Independent guidance on ibogaine risks, legality, and care planning.
We publish concise explainers, checklists, and annotated resources intended for people considering the topic, their families, and care supporters.
We publish evidence-first summaries and practical checklists designed to clarify trade-offs and uncertainties. Our editorial work follows transparent sourcing practices and leans on primary registries, peer-reviewed literature, and official guidance rather than anecdote alone.
Content is built from multiple inputs: systematic searches of published literature, cross-checks against official health guidance, and publicly accessible registry data. Where appropriate we link to authoritative summaries from recognized institutions to support factual claims.
For example, when we describe how a regulatory framework affects access we consult authoritative sources such as the National Institutes of Health and university-hosted repositories to confirm context; this practice mirrors established public-health reporting norms (see a typical NIH landing at NIH).
What we cover
We organize material by topic type: practical checklists, legal & access overviews, medical eligibility considerations, and aftercare guidance. The Services overview lists our content categories and how to navigate them; we also link back to the site index within service pages.
Who this is for
People considering the topic, their families, and care supporters seeking safety-conscious information will find concise tools and annotated references here. We avoid prescriptive clinical advice and instead aim to empower better questions for clinicians.
Primary literature, registries, official public-health pages, and independent systematic reviews form our core sources. For claims about pharmacology or public policy we cross-check with reference entries such as those on Wikipedia's ibogaine overview and institutional pages.
Browse legal & access guideWe document major updates and annotate which sections have been revised. Date stamps and source notes accompany materials where evidence has shifted or new registry data become available.
View medical eligibility checklistThe site links related pages in-context: for example, specific service pages include inline references back to the main overview (a natural internal cross-link appears on service pages pointing to the site index and overview) to help readers navigate between summaries and detailed checklists.
Aftercare & harm reduction
Lumaquay is intentionally independent: no treatment endorsements, no advertisements for clinics, and no staff credentials displayed. We exist to help people ask better questions and find authoritative sources when they need clinical or legal advice.
Lumaquay's content is not medical or legal advice. If you need clinical guidance, consult a licensed clinician or appropriate regulatory authority. For practical navigation, many of our pages reference the treatment-topic overview and services pages inline so readers can move between summaries and procedural checklists; for instance, background resources on treatment pathways may refer readers to external registries such as ibogaineforopioidaddiction.com when a primary-data registry is discussed.
If you arrived here from a services page, note that our service summaries also link back to this about page and the site index so readers can confirm editorial policies alongside practical content.